A longitudinal PET study on changes in brain norepinephrine transporter availability following duloxetine treatment in major depressive disorder.

Saved in:
Bibliographic Details
Title: A longitudinal PET study on changes in brain norepinephrine transporter availability following duloxetine treatment in major depressive disorder.
Authors: Moriguchi S; Advanced Neuroimaging Center, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology (QST), Chiba, Japan.; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Takahata K; Advanced Neuroimaging Center, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology (QST), Chiba, Japan.; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Takano H; Department of Psychiatry, National Center of Neurology and Psychiatry, Tokyo, Japan., Endo H; Advanced Neuroimaging Center, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology (QST), Chiba, Japan., Tagai K; Advanced Neuroimaging Center, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology (QST), Chiba, Japan., Kitamura S; Advanced Neuroimaging Center, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology (QST), Chiba, Japan., Uchida H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Kubota M; Department of Neuropsychiatry, Kyoto University, Kyoto, Japan., Zhang MR; Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology (QST), Chiba, Japan., Higuchi M; Advanced Neuroimaging Center, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology (QST), Chiba, Japan.
Source: The international journal of neuropsychopharmacology [Int J Neuropsychopharmacol] 2025 Oct 01; Vol. 28 (10).
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9815893 Publication Model: Print Cited Medium: Internet ISSN: 1469-5111 (Electronic) Linking ISSN: 14611457 NLM ISO Abbreviation: Int J Neuropsychopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1469-5111
DOI:10.1093/ijnp/pyaf064